Publication Year

Eskes C, Allen DG, Tice RR, Choksi NY, Truax JF, Chambers W, Stokes WS, Schechtman LM. In vitro models for ocular injury: Current and potential biomarkers. Presented at the 5th World Congress on Alternatives and Animal Use in the Life Sciences, Berlin, Germany, August 2005.

Haws L. Evaluating potential health risks posed by PCDDs, PCDFs, and dioxin-like PCBs: An approach for improving the Toxicity Equivalency Factor (TEF) methodology. 30th Annual Winter Meeting of the Toxicology Forum, Washington, DC, February 2005.

Scott PK, Unice KM, Panko JM. Statistical evaluation of metals concentrations as a method for identifying World Trade Center dust. International Society for Exposure Assessment 2005.

Unice KM, Panko JM, Scott PK. Considerations for reconstruction of TCE exposure from groundwater vapor intrusion. International Society for Exposure Assessment Conference, 2005.

Unice KM, Panko JM, Scott PK. Development of exposure assessment models for indoor air exposure to elemental mercury. International Society for Exposure Assessment Conference, 2005.

Panko JM, Unice KM, Brown JL. Comparison of toluene exposures during spray painting using various consumer product exposure models. International Society for Exposure Assessment Conference, 2005.

Rish W. 2005. A probabilistic risk assessment of Class I hazardous waste injection wells. Chapter 10 in Tsang C-F, Apps JA (eds.), Underground Injection Science and Technology, Developments in Water Sciences 52, Elsevier.

Ebeler SE, Dingley KH, Ubick E, Abel S, Mitchell AE, Burns SA, et al. 2005. Animal models and analytical approaches for understanding the relationships between wine and cancer. Drugs Exp Clin Res 31(1):19–27. PMID: 15921026.

Rickert DE, Dingley K, Ubick E, Dix KJ, Molina L. 2005. Determination of the tissue distribution and excretion by accelerator mass spectrometry of the nonadecapeptide 14C-Moli1901 in beagle dogs after intratracheal instillation. Chem Biol Interact 155(1–2):55–61; doi: 10.1016/j.cbi.2005.04.002. PMID: 15893299.

Bailer AJ, Wheeler MW, Dankovic D, Noble R, Bena J. 2005. Incorporating uncertainty and variability in the assessment of occupational hazards. Int J Risk Assess Manage 5(2-4):344-57; doi: 10.1504/IJRAM.2005.007176.

Fukuhara S, Nishimura M, Nordyke RJ, Zaher CA, Peabody JW. 2005. Patterns of care for COPD by Japanese physicians. Respirology 10(3):341-8; doi: 10.1111/j.1440-1843.2005.00717.x. PMID: 15955147.

Brown K, Dingley KH, Turteltaub KW. 2005. Accelerator mass spectrometry for biomedical research. Methods Enzymol 402:423–443; doi: 10.1016/S0076-6879(05)02014-8. PMID: 16401518.

Teeguarden JG, Waechter JM Jr, Clewell HJ 3rd, Covington TR, Barton HA. 2005. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding and uterine tissue dose metrics of bisphenol A: A physiologically based pharmacokinetic approach. Toxicol Sci 85(2):823–838; doi: 10.1093/toxsci/kfi135. PMID: 15746009.

Urban JD, Mailman RB. Functional selectivity as a mechanism of action for newer atypical antipsychotic drugs. Presented at Merck, West Point, PA, 2005.

Choksi NY. Current in vitro models of ocular injury and recovery: Vascular assays. Presented at the ICCVAM/NICEATM/ECVAM Ocular Toxicity Scientific Symposium on Mechanisms of Chemically-Induced Ocular Injury and Recovery, May 2005.

Banine F, Bartlett C, Gunawardena R, Muchardt C, Yaniv M, Knudsen ES, Weissman BE, Sherman LS. 2005. SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation. Cancer Res 65(9):3542-7; doi: 10.1158/0008-5472.CAN-04-3554. PMID: 15867346.

Gentry PR, Haber LT, McDonald TB, Zhao Q, Covington T, Nance P, Clewell HJ III, Lipscomb JC, Barton HA. 2005. Data for physiologically based pharmacokinetic modeling in neonatal animals: Physiological parameters in mice and Sprague-Dawley rats. J Children’s Health 2(3–4):363–411; doi: 10.3109/15417060490970430.

Bailer AJ, Noble RB, Wheeler MW. 2005. Model uncertainty and risk estimation for experimental studies of quantal responses. Risk Anal 25(2):291-9; doi: 10.1111/j.1539-6924.2005.00590.x. PMID: 15876205.

Staskal DF, Diliberto JJ, DeVito MJ, Birnbaum LS. 2005. Inhibition of human and rat CYP1A2 by TCDD and dioxin-like chemicals. Toxicol Sci 84(2):225-31; doi: 10.1093/toxsci/kfi090. PMID: 15659567.

Teeguarden JG, Waechter JM, Clewell HJ, Covington TR, Barton HA. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding and uterine tissue dose metrics of bisphenol A: A physiologically based pharmacokinetic approach. Poster presented at Society of Toxicology 44th Annual Meeting, New Orleans, LA, March 2005.